Earnings History Data for PMV Pharmaceuticals (PMVP) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
PMV Pharmaceuticals
PMV Pharmaceuticals Inc.is a precision oncology company. It engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations. PMV Pharmaceuticals Inc.is headquartered in Cranbury, New Jersey.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29-02-2024 | AH | PMVP | PMV Pharmaceuticals | 96.00 | -0.31 | -0.39 | 0.00 | PMV Pharmaceuticals reports FY results [3/1/2024 10:35 AM] |
1.88 | 0.03 (1.62%) |
1.85 | 0.0 (0.00%) |
1.17 - 9.72 | 806,851 | 390,000 | 39,627 | ||
| 09-11-2023 | PM | PMVP | PMV Pharmaceuticals | 106.00 | -0.34 | -0.45 | 0.00 | PMV Pharmaceuticals GAAP EPS of -$0.34 beats by $0.10 [11/9/2023 1:22 PM] |
1.91 | 0.05 (2.69%) |
1.81 | -0.05 (-2.69%) |
1.17 - 12.11 | 658,737 | 930,000 | 5,808 | ||
| 01-03-2023 | PM | PMVP | PMV Pharmaceuticals | 333.00 | -0.43 | -0.44 | 0.00 | PMV Pharmaceuticals GAAP EPS of -$1.61 beats by $0.03 [3/1/2023 8:55 AM] |
6.18 | -1.03 (-14.22%) |
0.0 | 0.0 (0.00%) |
6.09 - 24.26 | 591,695 | 560,000 | 0 | ||
| 08-11-2022 | PM | PMVP | PMV Pharmaceuticals | 515.00 | -0.40 | -0.42 | 0.00 | PMV Pharmaceuticals GAAP EPS of -$0.40 beats by $0.02 [11/8/2022 9:21 AM] |
10.37 | 0.21 (2.07%) |
10.16 | 0.0 (0.00%) |
8.99 - 25.85 | 532,179 | 490,000 | 2,614 | ||
| 09-08-2022 | PM | PMVP | PMV Pharmaceuticals | 777.00 | -0.38 | -0.41 | 0.00 | PMV Pharmaceuticals GAAP EPS of -$0.38 beats by $0.04 [8/9/2022 8:42 AM] |
15.73 | -1.38 (-8.09%) |
17.12 | 0.0 (0.00%) |
8.99 - 36.89 | 661,499 | 530,000 | 42,105 | ||
| 10-05-2022 | PM | PMVP | PMV Pharmaceuticals | 581.00 | -0.41 | -0.42 | 0.00 | PMV Pharmaceuticals GAAP EPS of -$0.41 beats by $0.01 [5/10/2022 7:53 AM] |
13.40 | 1.39 (11.62%) |
12.02 | 0.01 (0.08%) |
11.88 - 37.32 | 863,726 | 952,136 | 3,911 | ||
| 01-03-2022 | PM | 7:15 AM ET (Mar 1) |
PMVP | PMV Pharmaceuticals | 732.00 | -0.41 | -0.35 | 0.00 | PMV Pharmaceuticals GAAP EPS of -$1.28 misses by $0.05 [3/1/2022 7:51 AM] |
16.54 | 0.70 (4.42%) |
0.0 | 0.0 (0.00%) |
14.42 - 43.63 | 229,329 | 1,390,000 | 0 | |
|
||||||||||||||||||
| 14-05-2021 | PM | PMVP | Pmv Pharmaceuticals, Inc. | 1,273 | -0.26 | -0.26 | 0.00 | PMV Pharmaceuticals reports Q1 results [5/14/2021 8:58 AM] |
32.06 | 3.03 (10.44%) |
29.03 | 0.0 (0.00%) |
26.38 - 63.22 | 207,824 | 220,000 | 476 | ||
| 03-03-2021 | AH | PMVP | Pmv Pharmaceuticals, Inc. | 1,565 | 3.53 | -1.27 | 0.00 | PMV Pharmaceuticals EPS misses by $1.24 [3/3/2021 4:35 PM] |
34.84 | -0.34 (-0.95%) |
35.18 | 0.0 (0.00%) |
31.05 - 63.22 | 92,622 | 87,176 | 292 | ||
| 03-03-2021 | AH | PMVP | PMV Pharmaceuticals, Inc. | 1,570 | 3.53 | -1.27 | 0.00 | PMV Pharmaceuticals EPS misses by $1.24 [3/3/2021 4:35 PM] |
34.40 | -0.70 (-2.01%) |
35.10 | 0.0 (0.00%) |
31.05 - 63.22 | 89,786 | 95,087 | 1,476 | ||
|
|
||||||||||||||||||